Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Theravance BiopharmaMadrigal PharmaceuticalsNabriva TherapeuticsIGM BiosciencesBELLUS Health
SymbolNASDAQ:TBPHNASDAQ:MDGLNASDAQ:NBRVNASDAQ:IGMSOTCMKTS:BLUSF
Price Information
Current Price$21.13$68.73$0.62$46.48N/A
52 Week RangeBuyBuyBuyBuyN/A
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyN/A
Consensus Price Target$36.00$159.17$5.14$35.00N/A
% Upside from Price Target70.37% upside131.58% upside736.10% upside-24.70% downsideN/A
Trade Information
Market Cap$1.47 billion$1.11 billion$624.61 million$1.31 billion$1.27 billion
Beta1.730.961.97N/A1.55
Average Volume471,448219,4061,886,171146,86961,933
Sales & Book Value
Annual Revenue$73.41 millionN/A$9.48 millionN/A$30,000.00
Price / Sales18.13N/A61.40N/A0.00
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value($3.94) per share$27.00 per share$0.04 per shareN/A$0.25 per share
Price / Book-5.36N/A15.38N/A0.00
Profitability
Net Income$-236,460,000.00$-83,950,000.00$-82,760,000.00N/A$-7,010,000.00
EPS($4.25)($5.45)($1.12)($4.80)N/A
Trailing P/E RatioN/AN/AN/AN/A0.00
Forward P/E RatioN/AN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-322.08%N/A-872.95%N/A-49,910.34%
Return on Equity (ROE)N/A-18.84%-179.92%N/A-48.37%
Return on Assets (ROA)-50.37%-18.17%-89.03%N/A-45.25%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/AN/A0.84%0.03%N/A
Current Ratio3.03%17.52%5.48%38.62%13.87%
Quick Ratio3.03%17.52%5.44%38.62%13.87%
Ownership Information
Institutional Ownership Percentage71.64%67.83%3.25%40.89%N/A
Insider Ownership Percentage6.60%47.69%3.32%N/A24.17%
Miscellaneous
Employees36317N/A4010
Shares Outstanding63.00 million15.43 million946.23 million30.53 million159.12 million
Next Earnings Date5/5/2020 (Estimated)5/13/2020 (Estimated)5/8/2020 (Estimated)6/25/2020 (Estimated)N/A
OptionableOptionableOptionableOptionableNot OptionableNot Optionable
Comparison Ideas:
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel